logo

For the Inventor, By the Inventor

Lake Forest, IL, United States of America

Hospira, Inc.


USPTO Granted Patents = 133

% Expired Patents = 15.0



Trademarks = 54

Forward Citations = 10,191

Loading Chart...
Loading Chart...

198 inventors (with patents filed for the assignee):

goldMedal Marwan A Fathallah (34 out of 37 patents)

silverMedal John Stephen Ziegler (28 out of 47 patents)

bronzeMedal John A Domkowski (16 out of 17 patents)

4.  Mihaela Cozmi (12 out of 14 patents)

5.  Glenn Davis (12 out of 23 patents)

6.  Yei Feng Moy (12 out of 12 patents)

7.  Patrick B Keely (11 out of 13 patents)

8.  Stanley F Pytel (11 out of 11 patents)

9.  Raymond P Silkaitis (10 out of 14 patents)

10.  Geoffrey N Holland (9 out of 11 patents)

11.  Suzanne Willey (9 out of 9 patents)

12.  Michael G Lowery (9 out of 25 patents)

13.  James Duane Jacobson (8 out of 31 patents)

14.  Jesse Darley (8 out of 59 patents)

15.  Douglas S Rodenkirch (8 out of 41 patents)


Core Competencies:
Infusion Pump
Medication Management
Drug Admixing
Fluid Delivery
Dexmedetomidine
Flow Sensor
User Interface
Occlusion Detection
Spray Drying
Automated Testing
Medical Device

133 patents:

1. 11224555 - Access and vapor containment system for a drug vial and method of making and using same (2022-01-18),
2. 10512591 - Cartridge assembly for an injection system (2019-12-24),
3. 10039887 - Injection system (2018-08-07),
4. 10016396 - Dexmedetomidine premix formulation (2018-07-10),
5. 9763997 - Spray drying vancomycin (2017-09-19),
6. 9616049 - Dexmedetomidine premix formulation (2017-04-11),
7. 9610223 - System and method for intermixing the contents of two containers (2017-04-04),
8. 9594875 - Medical device update system (2017-03-14),
9. 9572923 - System for maintaining drug information and communicating with medication delivery devices (2017-02-21),
10. 9539383 - System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein (2017-01-10),
11. 9498583 - Froth detection system and method (2016-11-22),
12. 9468718 - Means and method for detecting free flow in an infusion line (2016-10-18),
13. 9468713 - Apparatus and method of mitigating free flow in a fluid administration set (2016-10-18),
14. 9393362 - Infusion pump with configurable screen settings (2016-07-19),
15. 9381296 - Infusion pump with configurable screen settings (2016-07-05),
Company Overview
Hospira, Inc., headquartered in Lake Forest, Illinois, specializes in the development and manufacturing of medication delivery systems. The company focuses on advanced technologies in infusion pumps, medication management, and drug admixing, providing critical solutions for healthcare settings. With a strong emphasis on fluid delivery and user interface design, Hospira integrates features such as occlusion detection and flow sensors to enhance patient safety and treatment efficacy. Its innovations support healthcare professionals in delivering precise and reliable medication administration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Hospira, Inc. USPTO Patent Assignee Logo
133 Patents

#5 in Lake Forest, IL

#176 in Illinois

#2,917 in US

#6,064 in the World

Lake Forest, IL (US)
Lake Forest, IL, United States of America

Hospira, Inc.

Forward Citations = 10,191

198 inventors:

goldMedal Marwan A Fathallah (34 out of 37 patents)

silverMedal John Stephen Ziegler (28 out of 47 patents)

bronzeMedal John A Domkowski (16 out of 17 patents)

4.  Mihaela Cozmi (12 out of 14 patents)

5.  Glenn Davis (12 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hospira, Inc.. Retrieved from https://idiyas.com/company/hospira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…